BTA
Click for more information
0.00% 57.0¢ biota holdings limited

check this out

  1. PortableAlpha
    3,045 Posts.
    clock Created with Sketch.
    12/05/09
    23:04
    Post #: 5127939
    From the Daiichi Sankyo annual report:

    " Phase III clinical trials were completed in Japan for the anti-influenza drug CS-8958. The Company plans to submit an application for regulatory approval during fiscal 2009."

    Note they have a slightly different FY. Sounds like they are still positive on the trial.
    BTA Price at posting: $1.10 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS MiningNews Select Conference: Inflation and global shifts pose funding challenges for Aus miners
right-arrow Created with Sketch.
CC9 Chariot Corporation marches forward with discovery-level drill program in Wyoming, USA
right-arrow Created with Sketch.
NEWS Week 24 Wrap: US contagion sentiment not so contagious; iron ore remains pressured
right-arrow Created with Sketch.
GT1 Green Technology hands the helm to Henry
right-arrow Created with Sketch.
EMD Emyria's Empax Centre chosen for mental health clinical trial
right-arrow Created with Sketch.
NEWS Drill, drill, drill: 3 explorers with news on Friday – Sun Silver, Aurelia & PNX Metals
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.